Online inquiry

IVTScrip™ mRNA-Human ARRDC1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26877MR)

This product GTTS-WK26877MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARRDC1 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001317968.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 92714
UniProt ID Q8N5I2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARRDC1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26877MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26850MR IVTScrip™ mRNA-Human ARL6IP6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP6
GTTS-WK7408MR IVTScrip™ mRNA-Human ADAMTSL1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ADAMTSL1
GTTS-WK8387MR IVTScrip™ mRNA-Human AFTPH, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA AFTPH
GTTS-WK10328MR IVTScrip™ mRNA-Human ACKR4, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ACKR4
GTTS-WK22379MR IVTScrip™ mRNA-Human ARRDC2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARRDC2
GTTS-WK4221MR IVTScrip™ mRNA-Human Go-alpha, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA Go-alpha
GTTS-WK18504MR IVTScrip™ mRNA-Human ANKRD18A, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD18A
GTTS-WK12199MR IVTScrip™ mRNA-Human ADAMTS14, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADAMTS14
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW